SURGERY: Cetuximab—an option for unresectable CRC liver metastases

    loading  Checking for direct PDF access through Ovid

Abstract

In patients with colorectal cancer, resection of liver-limited metastatic disease provides the only chance of cure. A recent study showed that the addition of cetuximab to conventional chemotherapy significantly increased the response rate and the rate of liver metastases resection in patients with colorectal cancer, providing another chance to cure patients with initially liver-limited unresectable disease.

Related Topics

    loading  Loading Related Articles